News

MUSC study provides new insight that may lead to personalized repetitive transcranial magnetic stimulation, or rTMS, for smokers who want to quit.

Those born with both Down syndrome and congenital heart defects can still score just as high in quality of life and community engagement.

Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

A clinical trial at Hollings is looking for answers to a problem that Dr. Avi Siva saw was affecting her triple negative breast cancer patients.

Researchers find a nuanced approach to treating intracranial internal carotid artery aneurysms can be done safely and may get better outcomes.

MUSC study finds a link between inflammation and poor neonatal and pregnancy outcomes.

A new microcredential from Hollings Cancer Center highlights the work of future cancer researchers, who are learning both science and compassion.

As people across country cope with aftermath of shooting that killed two children during a Catholic Mass, MUSC-based center is helping with recovery.

MUSC Hollings Cancer Center researchers are working on a new drug that destroys cancer cells' energy factories.

New trial to test whether quit-smoking medication works to help people to quit vaping.